Back to Journals » Drug Design, Development and Therapy » Volume 12

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Total article views   HTML views PDF downloads Totals
13,256 Dovepress* 11,774+ 928 12,702
PubMed Central* 1,482 289 1,771
Totals 13,256 1,217 14,473
*Since 19 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar